Skip to content

Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs

CompletedNot applicableNCT02143791
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to confirm long term efficacy and safety of the ProdigyTM neuromodulation system in the management of failed back surgery syndrome or chronic intractable pain of the trunk and/or limbs.

Study details

Official title
A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs.
Conditions
Interventions
  • Procedure: Burst and Tonic stimulation
Sponsor
Abbott Medical Devices
Start date
2014-06
Primary completion
2016-01
Sex
All
Age range
from 18 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
Australia, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden, United Kingdom
Total sites listed
21

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient with chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome or intractable low back and/or leg pain * Patient diagnosed with radiculopathy * Patient diagnosed with neuropathic pain * Patient is considered by the investigator as a candidate for implantation of a SCS system * Patient is ≥ 18 years of age * Patient must be willing and able to comply with study requirements * Patient must indicate his/her understanding of the study and willingness to participate by signing an appropriate Informed Consent Form Exclusion Criteria: * Patient is diagnosed with ischemic pain * Patient is diagnosed with arachnoiditis * Patient is diagnosed with complex regional pain syndrome (CRPS I and II) * Patient is diagnosed with peripheral vascular disease (PVD) * Patient is diagnosed with diabetic neuropathic pain * Patient is diagnosed with chronic migraine * Patient is immune-compromised * Patient has history of cancer requiring active treatment in the last 6 months * Patient has a documented history of substance abuse (narcotics, alcohol, etc.) or substance dependency in the last 6 months * Patients with a SCS system or implantable infusion pump implanted previously * Patient has a life expectancy of less than one year * Patient is pregnant or is planning to become pregnant during the duration of the investigation * Patient is unable to comply with the follow up schedule * Patient needing legally authorized representative * Patient unable to read and write * Patient is currently participating in another clinical investigation with an active treatment arm.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02143791